Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

Clinical trial NCT00310011 · COMPLETED

Trial details

NCT number: NCT00310011
Sponsor: Wake Forest University Health Sciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter

Start date: 1998-06-01
Primary completion: 2005-10-01
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.